Avanos Medical (AVNS) Revenue (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.72% |
| Dec 31, 2025 | 1.74% |
| Sep 30, 2025 | 1.60% |
| Jun 30, 2025 | 4.48% |
| Mar 31, 2025 | -6.74% |
| Dec 31, 2024 | 5.40% |
| Sep 30, 2024 | -0.76% |
| Jun 30, 2024 | 3.37% |
| Mar 31, 2024 | -4.15% |
| Dec 31, 2023 | 1.17% |
| Sep 30, 2023 | 1.12% |
| Jun 30, 2023 | 6.34% |
| Mar 31, 2023 | -12.28% |
| Dec 31, 2022 | 5.40% |
| Sep 30, 2022 | 0.82% |
| Jun 30, 2022 | -13.42% |
| Mar 31, 2022 | 451.40% |
| Dec 31, 2021 | -80.55% |
| Sep 30, 2021 | -1.23% |
| Jun 30, 2021 | 3.15% |
| Mar 31, 2021 | -2.32% |
| Dec 31, 2020 | -0.38% |
| Sep 30, 2020 | 13.44% |
| Jun 30, 2020 | -9.26% |
| Mar 31, 2020 | -4.95% |
| Dec 31, 2019 | 10.74% |
| Sep 30, 2019 | -0.46% |
| Jun 30, 2019 | 4.87% |
| Mar 31, 2019 | -3.35% |
| Dec 31, 2018 | 2.91% |
| Sep 30, 2018 | 2.61% |
| Jun 30, 2018 | 2.88% |
| Mar 31, 2018 | -5.95% |
| Dec 31, 2017 | 10.50% |
| Sep 30, 2017 | 0.94% |
| Jun 30, 2017 | 2.33% |
| Mar 31, 2017 | 123.65% |
| Dec 31, 2016 | -254.99% |
| Sep 30, 2016 | -0.62% |
| Jun 30, 2016 | 3.95% |
| Mar 31, 2016 | 157.95% |
| Dec 31, 2015 | -270.47% |
| Sep 30, 2015 | 0.05% |
| Jun 30, 2015 | -1.24% |
| Mar 31, 2015 | -10.29% |
| Dec 31, 2014 | 7.56% |
| Sep 30, 2014 | -1.21% |
| Jun 30, 2014 | 0.68% |
| Mar 31, 2014 | -4.78% |
| Dec 31, 2013 | 2.81% |